220 related articles for article (PubMed ID: 14644467)
1. Role of corticotropin-releasing factor and its receptor in nociceptive modulation in the central nucleus of amygdala in rats.
Cui XY; Lundeberg T; Yu LC
Brain Res; 2004 Jan; 995(1):23-8. PubMed ID: 14644467
[TBL] [Abstract][Full Text] [Related]
2. Traumatic Stress Promotes Hyperalgesia via Corticotropin-Releasing Factor-1 Receptor (CRFR1) Signaling in Central Amygdala.
Itoga CA; Roltsch Hellard EA; Whitaker AM; Lu YL; Schreiber AL; Baynes BB; Baiamonte BA; Richardson HN; Gilpin NW
Neuropsychopharmacology; 2016 Sep; 41(10):2463-72. PubMed ID: 27013358
[TBL] [Abstract][Full Text] [Related]
3. Nicotine dependence produces hyperalgesia: role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA).
Baiamonte BA; Valenza M; Roltsch EA; Whitaker AM; Baynes BB; Sabino V; Gilpin NW
Neuropharmacology; 2014 Feb; 77():217-23. PubMed ID: 24107576
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CGRP and CGRP1 receptor in nociception in the nucleus accumbens of rats.
Li N; Lundeberg T; Yu LC
Brain Res; 2001 May; 901(1-2):161-6. PubMed ID: 11368963
[TBL] [Abstract][Full Text] [Related]
5. Analgesia and hyperalgesia from CRF receptor modulation in the central nervous system of Fischer and Lewis rats.
Vit JP; Clauw DJ; Moallem T; Boudah A; Ohara PT; Jasmin L
Pain; 2006 Apr; 121(3):241-260. PubMed ID: 16495007
[TBL] [Abstract][Full Text] [Related]
6. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors.
Ji G; Neugebauer V
J Neurophysiol; 2008 Mar; 99(3):1201-12. PubMed ID: 18171711
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway.
Xu W; Lundeberg T; Wang YT; Li Y; Yu LC
Neuroscience; 2003; 118(4):1015-22. PubMed ID: 12732246
[TBL] [Abstract][Full Text] [Related]
8. Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors.
Hein M; Ji G; Tidwell D; D'Souza P; Kiritoshi T; Yakhnitsa V; Navratilova E; Porreca F; Neugebauer V
Neuropharmacology; 2021 Mar; 185():108456. PubMed ID: 33444637
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CGRP and CGRPl receptor in nociception in the basolateral nucleus of amygdala of rats.
Li N; Liang J; Fang CY; Han HR; Ma MS; Zhang GX
Neurosci Lett; 2008 Oct; 443(3):184-7. PubMed ID: 18687383
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing factor in the rat amygdala differentially influences sensory-discriminative and emotional-like pain response in peripheral neuropathy.
Bourbia N; Ansah OB; Pertovaara A
J Pain; 2010 Dec; 11(12):1461-71. PubMed ID: 20624690
[TBL] [Abstract][Full Text] [Related]
11. GABAA receptors in the central nucleus of amygdala (CeA) affect on pain modulation.
Hasanein P; Mirazi N; Javanmardi K
Brain Res; 2008 Nov; 1241():36-41. PubMed ID: 18838064
[TBL] [Abstract][Full Text] [Related]
12. Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses.
Ji G; Fu Y; Adwanikar H; Neugebauer V
Mol Pain; 2013 Feb; 9():2. PubMed ID: 23410057
[TBL] [Abstract][Full Text] [Related]
13. Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.
Taché Y
Neurogastroenterol Motil; 2015 Jan; 27(1):1-6. PubMed ID: 25557223
[TBL] [Abstract][Full Text] [Related]
14. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala.
Ji G; Neugebauer V
J Neurophysiol; 2007 Jun; 97(6):3893-904. PubMed ID: 17392412
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.
Beckerman MA; Van Kempen TA; Justice NJ; Milner TA; Glass MJ
Exp Neurol; 2013 Jan; 239():120-32. PubMed ID: 23063907
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats.
Funk CK; O'Dell LE; Crawford EF; Koob GF
J Neurosci; 2006 Nov; 26(44):11324-32. PubMed ID: 17079660
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effects induced by injection of the galanin receptor 1 agonist M617 into central nucleus of amygdala in rats.
Li J; Zhang JJ; Xu SL; Yu LC
Neurosci Lett; 2012 Sep; 526(1):45-8. PubMed ID: 22884928
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effects of galanin in the central nucleus of amygdala of rats, an involvement of opioid receptors.
Jin WY; Liu Z; Liu D; Yu LC
Brain Res; 2010 Mar; 1320():16-21. PubMed ID: 20051236
[TBL] [Abstract][Full Text] [Related]
20. The effect of morphine on MC4 and CRF receptor mRNAs in the rat amygdala and attenuation of tolerance after their blockade.
Starowicz K; Sieja A; Bilecki W; Obara I; Przewlocka B
Brain Res; 2003 Nov; 990(1-2):113-9. PubMed ID: 14568335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
